C.L. Witzleben

2.2k total citations
53 papers, 1.4k citations indexed

About

C.L. Witzleben is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C.L. Witzleben has authored 53 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 9 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C.L. Witzleben's work include Pediatric Hepatobiliary Diseases and Treatments (7 papers), Hemoglobinopathies and Related Disorders (6 papers) and Biomedical Research and Pathophysiology (5 papers). C.L. Witzleben is often cited by papers focused on Pediatric Hepatobiliary Diseases and Treatments (7 papers), Hemoglobinopathies and Related Disorders (6 papers) and Biomedical Research and Pathophysiology (5 papers). C.L. Witzleben collaborates with scholars based in United States, Canada and Australia. C.L. Witzleben's co-authors include Virginia H. Peden, Antonia Uri, Shirley G. Driscoll, John P. Wyatt, Jane Chatten, M P Banner, Stuart Weiner, Charles G. Howell, Mark S. Glassman and John Michael Templeton and has published in prestigious journals such as Nature, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

C.L. Witzleben

53 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C.L. Witzleben United States	19	401	307	296	209	192	53	1.4k
William S. Hammond United States	24	282 0.7×	134 0.4×	473 1.6×	149 0.7×	333 1.7×	37	2.0k
H. O. Nieweg Netherlands	19	210 0.5×	95 0.3×	135 0.5×	72 0.3×	186 1.0×	73	1.3k
J. Brodehl Germany	28	366 0.9×	88 0.3×	409 1.4×	505 2.4×	541 2.8×	104	2.2k
J. Lawrence Naiman United States	20	191 0.5×	92 0.3×	171 0.6×	325 1.6×	425 2.2×	56	1.6k
William R. Griswold United States	20	129 0.3×	92 0.3×	255 0.9×	105 0.5×	217 1.1×	67	1.2k
Darlene A Calhoun United States	24	144 0.4×	326 1.1×	481 1.6×	218 1.0×	88 0.5×	80	1.5k
Joachim Misselwitz Germany	27	253 0.6×	248 0.8×	358 1.2×	663 3.2×	529 2.8×	51	2.4k
José Strauss United States	22	142 0.4×	72 0.2×	288 1.0×	282 1.3×	181 0.9×	72	1.3k
B. A. Chapman New Zealand	23	762 1.9×	205 0.7×	232 0.8×	68 0.3×	125 0.7×	44	2.0k
C. G. Halgrimson United States	15	594 1.5×	86 0.3×	275 0.9×	119 0.6×	82 0.4×	22	1.4k

Countries citing papers authored by C.L. Witzleben

Since Specialization

Citations

This map shows the geographic impact of C.L. Witzleben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.L. Witzleben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.L. Witzleben more than expected).

Fields of papers citing papers by C.L. Witzleben

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.L. Witzleben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.L. Witzleben. The network helps show where C.L. Witzleben may publish in the future.

Co-authorship network of co-authors of C.L. Witzleben

This figure shows the co-authorship network connecting the top 25 collaborators of C.L. Witzleben. A scholar is included among the top collaborators of C.L. Witzleben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.L. Witzleben. C.L. Witzleben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berry, Gerard T., et al.. (1995). Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome. Pediatric Nephrology. 9(3). 287–291. 31 indexed citations

Witzleben, C.L., David A. Piccoli, & Kenneth D.R. Setchell. (1992). Case 3 A New Category of Causes of Intrahepatic Cholestasis. Pediatric Pathology. 12(2). 269–274. 15 indexed citations

Ruchelli, Eduardo D., Antonia Uri, James E. Dimmick, et al.. (1991). Severe perinatal liver disease and down syndrome: An apparent relationship. Human Pathology. 22(12). 1274–1280. 61 indexed citations

Restaino, Irene, et al.. (1991). Renal dysgenesis in a monozygotic twin: Association with in utero exposure to indomethacin. American Journal of Medical Genetics. 39(3). 252–257. 24 indexed citations

George, Anna, Susanne Kost, C.L. Witzleben, John J. Cebra, & D H Rubin. (1990). Reovirus-induced liver disease in severe combined immunodeficient (SCID) mice. A model for the study of viral infection, pathogenesis, and clearance.. The Journal of Experimental Medicine. 171(3). 929–934. 36 indexed citations

Piccoli, David A., et al.. (1990). Synergism between hepatic injuries and a nonhepatotropic reovirus in mice. Enhanced hepatic infection and death.. Journal of Clinical Investigation. 86(4). 1038–1045. 10 indexed citations

Witzleben, C.L. & Antonia Uri. (1989). Perinatal hemochromatosis: Entity or end result?. Human Pathology. 20(4). 335–340. 55 indexed citations

Witzleben, C.L., et al.. (1988). HIV as a cause of giant cell hepatitis. Human Pathology. 19(5). 603–605. 35 indexed citations

Witzleben, C.L., Milton J. Finegold, David A. Piccoli, & William R. Treem. (1987). Bile canalicular morphometry in arteriohepatic dysplasia. Hepatology. 7(6). 1262–1266. 2 indexed citations

10.

Uri, Antonia, C.L. Witzleben, & R. Beverly Raney. (1984). Electron microscopy of glandular schwannoma. Cancer. 53(3). 493–497. 30 indexed citations

11.

Witzleben, C.L., et al.. (1982). “Nephronophthisis—congenital hepatic fibrosis”: An additional hepatorenal disorder. Human Pathology. 13(8). 728–733. 26 indexed citations

12.

Norman, Maia, et al.. (1977). Acute renal failure secondary to acute pyelonephritis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 8(3). 400–3. 7 indexed citations

13.

Witzleben, C.L., et al.. (1975). Bilirubin as a cholestatic agent. III. Prevention of bilirubin-related cholestasis by sulfobromophthalein.. PubMed. 99(9). 492–5. 5 indexed citations

14.

Witzleben, C.L., Keith Smith, J. Stuart Nelson, Patricia L. Monteleone, & D. C. Livingston. (1971). Ultrastructural studies in late-onset amauroticidiocy: Lymphocyte inclusions as a diagnostic marker. The Journal of Pediatrics. 79(2). 285–293. 30 indexed citations

15.

Witzleben, C.L.. (1971). Bilirubin as a cholestatic agent. Physiologic and morphologic observations.. PubMed. 62(2). 181–94. 17 indexed citations

16.

Witzleben, C.L., et al.. (1970). Gaucher's cells in acute leukemia of childhood. The Journal of Pediatrics. 76(1). 129–131. 11 indexed citations

17.

Witzleben, C.L., et al.. (1968). Infantile choriocarcinoma: A characteristicsyndrome. The Journal of Pediatrics. 73(3). 374–378. 43 indexed citations

18.

Witzleben, C.L.. (1966). Hereditary Hyperoxaluria. American journal of diseases of children. 111(1). 56–56. 1 indexed citations

19.

Witzleben, C.L.. (1965). Complete Frontal Septum of the Bladder. The Journal of Urology. 94(4). 427–429. 8 indexed citations

20.

Witzleben, C.L. & Nigel Chaffey. (1962). A STUDY OF IRON-INDUCED LIVER DAMAGE. The Journal of Experimental Medicine. 115(4). 723–729. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact